Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BELDEN INC. Director's Dealing 2017

Mar 3, 2017

31053_dirs_2017-03-03_8cfd2cc6-4fe7-4940-b6d9-ab1e50b595e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2017-02-23

Reporting Person: Turner Paul Keith (SVP, Sales)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5522 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Appreciation Rights $21.70 2020-02-22 Common Stock (1686) Direct
Stock Appreciation Rights $35.83 2021-03-01 Common Stock (7030) Direct
Stock Appreciation Rights $39.83 2022-02-27 Common Stock (4200) Direct
Stock Appreciation Rights $50.01 2023-03-04 Common Stock (2280) Direct
Stock Appreciation Rights $72.57 2024-03-04 Common Stock (1114) Direct
Stock Appreciation Rights $89.23 2025-02-25 Common Stock (1065) Direct
Stock Appreciation Rights $52.89 2026-02-24 Common Stock (1806) Direct
Stock Appreciation Rights $74.91 2027-02-22 Common Stock (4210) Direct

Footnotes

F1: Consists of previously granted restricted stock units that will vest between 2017 and 2019.

F2: 2,344 SARs became exercisable on March 1, 2012, 2,343 SARs became exercisable on March 1, 2013 and 2,343 SARs became exercisable on March 1, 2014.

F3: 1,400 SARs became exercisable on February 27, 2013, 1,400 SARs became exercisable on February 27, 2014 and 1,400 SARs became exercisable on February 27, 2015.

F4: 760 SARs became exercisable on March 4, 2014, 760 SARs became exercisable on March 4, 2015 and 760 became exercisable on March 4, 2016.

F5: 372 SARs became exercisable on March 4, 2015, 371 SARs became exercisable on March 4, 2016 and 371 will become exercisable on March 4, 2017.

F6: 355 SARs became exercisable on February 25, 2016 and 355 SARs became exercisable on February 25, 2017. The remaining 355 SARs are scheduled to become exercisable on February 25, 2018.

F7: 602 SARs became exercisable on February 24, 2017. The remaining 1,204 SARs are scheduled to become exercisable in equal installments on February 24, 2018 and February 24, 2019.

F8: The SARs will become exercisable in equal installments on February 22, 2018, February 22, 2019 and February 22, 2020.